AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Turner, SD Wijnhoven, SWP Tinwell, H Lashford, LS Rafferty, JA Ashby, J Vrieling, H Fairbairn, LJ
Citation: Sd. Turner et al., Assays to predict the genotoxicity of the chromosomal mutagen etoposide - focussing on the best assay, MUT RES-GTE, 493(1-2), 2001, pp. 139-147

Authors: Fairbairn, LJ Chinnasamy, N Lashford, LS Chinnasamy, D Rafferty, JA
Citation: Lj. Fairbairn et al., Enhancing hemopoietic drug resistance: A rationale for reconsidering the clinical use of mitozolomide, CANC GENE T, 7(2), 2000, pp. 233-239

Authors: Turner, SD Rafferty, JA Fairbairn, LJ Ashby, J Tinwell, H Eckert, HG Baum, C Lashford, LS
Citation: Sd. Turner et al., The effects of dose, route of administration, drug scheduling and MDR-1 gene transfer on the genotoxicity of etoposide in bone marrow, LEUKEMIA, 14(10), 2000, pp. 1796-1802

Authors: Bellantuono, I Lashford, LS Rafferty, JA Fairbairn, LJ
Citation: I. Bellantuono et al., The expression of full length Gp91-Phox protein is associated with reducedamphotropic retroviral production, HAEMATOLOG, 85(5), 2000, pp. 451-457

Authors: Fairbairn, LJ Rafferty, JA Lashford, LS
Citation: Lj. Fairbairn et al., Engineering drug resistance in human cells, BONE MAR TR, 25, 2000, pp. S110-S113

Authors: Thompson, MJ Abdul-Rahman, S Baker, TG Rafferty, JA Margison, GP Bibby, MC
Citation: Mj. Thompson et al., Role of O-6-alkylguanine-DNA alkyltransferase in the resistance of mouse spermatogenic cells to O-6-alkylating agents, J REPR FERT, 119(2), 2000, pp. 339-346

Authors: Rajaguru, P Fairbairn, LJ Ashby, J Willington, MA Turner, S Woolford, LA Chinnasamy, N Rafferty, JA
Citation: P. Rajaguru et al., Genotoxicity studies on the azo dye Direct Red 2 using the in vivo mouse bone marrow micronucleus test, MUT RES-GTE, 444(1), 1999, pp. 175-180

Authors: Longhurst, SJ Rafferty, JA Arrand, JR Cortez, N Giraud, C Berns, KI Fairbairn, LJ
Citation: Sj. Longhurst et al., Recombinant adeno-associated virus-mediated expression of O-6-alkylguanine-DNA-alkyltransferase protects human epithelial and hematopoietic cells against chloroethylating agent toxicity, HUM GENE TH, 10(2), 1999, pp. 301-310

Authors: Jelinek, J Rafferty, JA Cmejla, R Hildinger, M Chinnasamy, D Lashford, LS Ostertag, W Margison, GP Dexter, TM Fairbairn, LJ Baum, C
Citation: J. Jelinek et al., A novel dual function retrovirus expressing multidrug resistance 1 and O-6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents, GENE THER, 6(8), 1999, pp. 1489-1493

Authors: Chinnasamy, N Rafferty, JA Lashford, LS Chinnasamy, D Margison, GP Thatcher, N Dexter, TM Fairbairn, LJ
Citation: N. Chinnasamy et al., Protection of committed murine haemopoietic progenitors against BCNU toxicity does not predict protection of primitive, multipotent spleen colony-forming cells - implications for chemoprotective gene therapy, LEUKEMIA, 13(11), 1999, pp. 1776-1783

Authors: Herring, CJ Deans, B Elder, RH Rafferty, JA MacKinnon, J Barzilay, G Hickson, ID Hendry, JH Margison, GP
Citation: Cj. Herring et al., Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines, BR J CANC, 80(7), 1999, pp. 940-945

Authors: Bibby, MC Thompson, MJ Rafferty, JA Margison, GP McElhinney, RS
Citation: Mc. Bibby et al., Influence of O-6-benzylguanine on the anti-tumour activity and normal tissue toxicity of 1,3-bis(2-chloroethyl)-l-nitrosourea and molecular combinations of 5-fluorouracil and 2-chloroethyl-1-nitrosourea in mice, BR J CANC, 79(9-10), 1999, pp. 1332-1339

Authors: McElhinney, RS Donnelly, DJ McCormick, JE Kelly, J Watson, AJ Rafferty, JA Elder, RH Middleton, MR Willington, MA McMurry, TBH Margison, GP
Citation: Rs. Mcelhinney et al., Inactivation of O-6-alkylguanine-DNA alkyltransferase. 1. Novel O-6-(hetarylmethyl)guanines having basic rings in the side chain, J MED CHEM, 41(26), 1998, pp. 5265-5271
Risultati: 1-13 |